EU medtech sector discusses how to avoid incompatible UDI schemes
This article was originally published in SRA
Executive Summary
EU medical device stakeholders are in talks over how to avoid the proliferation of device identification systems that would be incompatible with the future EU unique device identification (UDI) scheme, according to Mike Kreuzer, regulatory affairs director at the Association of British Healthcare Industries1.
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.